Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael O'Dwyer

Showing results (1-10 of 80) with videos related to

Pageof 8
Sort By:
The Oncologist|April 19, 2002
Multifaceted approach to the treatment of bcr-abl-positive leukemiasMichael O'Dwyer
Therapeutic Advances in Hematology|April 5, 2013
First-line treatment of chronic myeloid leukaemiaMichael O'Dwyer
Cancers|April 3, 2021
Realizing Innate Potential: CAR-NK Cell Therapies for Acute Myeloid LeukemiaMark Gurney, Michael O'Dwyer
Seminars in Hematology|July 23, 2009
Practical considerations for the management of patients in the tyrosine kinase inhibitor eraMichael O'Dwyer, Ehab Atallah
Cancers|May 13, 2023
Adoptive Immunotherapy and High-Risk MyelomaCatherine Duane, Michael O'Dwyer, Siobhan Glavey
Cytotherapy|January 12, 2021
Generating natural killer cells for adoptive transfer: expanding horizonsSoumyadipta Kundu, Mark Gurney, Michael O'Dwyer
Frontiers in Immunology|May 31, 2019
Sugar Free: Novel Immunotherapeutic Approaches Targeting Siglecs and Sialic Acids to Enhance Natural Killer Cell Cytotoxicity Against CancerJohn Daly, Mattias Carlsten, Michael O'Dwyer
Methods in Molecular Biology (Clifton, N.J.)|February 26, 2013
A cell culture system that mimics chronic lymphocytic leukemia cells microenvironment for drug screening and characterizationAlessandro Natoni, Michael O'Dwyer, Corrado Santocanale
Cellular and Molecular Life Sciences : CMLS|September 25, 2015
Neurotrophins and B-cell malignanciesJennifer Hillis, Michael O'Dwyer, Adrienne M Gorman
Molecular Cancer Therapeutics|June 5, 2013
Endoplasmic reticulum stress and the unfolded protein response: targeting the Achilles heel of multiple myelomaLisa Vincenz, Richard Jäger, Michael O'Dwyer, et al.
Pageof 8

Showing results (1-10 of 80) with videos related to

Sort By:
Pageof 8
The Oncologist|April 19, 2002
Multifaceted approach to the treatment of bcr-abl-positive leukemiasMichael O'Dwyer
Therapeutic Advances in Hematology|April 5, 2013
First-line treatment of chronic myeloid leukaemiaMichael O'Dwyer
Cancers|April 3, 2021
Realizing Innate Potential: CAR-NK Cell Therapies for Acute Myeloid LeukemiaMark Gurney, Michael O'Dwyer
Seminars in Hematology|July 23, 2009
Practical considerations for the management of patients in the tyrosine kinase inhibitor eraMichael O'Dwyer, Ehab Atallah
Cancers|May 13, 2023
Adoptive Immunotherapy and High-Risk MyelomaCatherine Duane, Michael O'Dwyer, Siobhan Glavey
Cytotherapy|January 12, 2021
Generating natural killer cells for adoptive transfer: expanding horizonsSoumyadipta Kundu, Mark Gurney, Michael O'Dwyer
Frontiers in Immunology|May 31, 2019
Sugar Free: Novel Immunotherapeutic Approaches Targeting Siglecs and Sialic Acids to Enhance Natural Killer Cell Cytotoxicity Against CancerJohn Daly, Mattias Carlsten, Michael O'Dwyer
Methods in Molecular Biology (Clifton, N.J.)|February 26, 2013
A cell culture system that mimics chronic lymphocytic leukemia cells microenvironment for drug screening and characterizationAlessandro Natoni, Michael O'Dwyer, Corrado Santocanale
Cellular and Molecular Life Sciences : CMLS|September 25, 2015
Neurotrophins and B-cell malignanciesJennifer Hillis, Michael O'Dwyer, Adrienne M Gorman
Molecular Cancer Therapeutics|June 5, 2013
Endoplasmic reticulum stress and the unfolded protein response: targeting the Achilles heel of multiple myelomaLisa Vincenz, Richard Jäger, Michael O'Dwyer, et al.
Pageof 8